Plain-English translation of NCT06192160 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether new combinations of tuberculosis medications—including , , and several other drugs—can work better and faster than the standard four-drug treatment. Researchers will compare how quickly these new medication combinations clear the bacteria from your lungs over the first 8 weeks, and then continue you on standard TB drugs for the remaining 18 weeks of treatment. The goal is to find a treatment that gets people well more quickly while staying safe.
Standard tuberculosis treatment works, but it takes a long time and can have side effects. This study is looking for faster, more effective alternatives that could help TB patients recover more quickly and hopefully with fewer problems.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the standard four-drug TB treatment or one of the new medication combinations. You'll take your assigned medications daily for the first 8 weeks, then switch to standard TB drugs (or continue them) for another 18 weeks. During the first 8 weeks, researchers will frequently test your sputum samples to measure how quickly the bacteria are dying. The entire study lasts 52 weeks, with regular clinic visits for blood tests, medication refills, and check-ins on how you're doing.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Botswana
Brazil
Haiti